Clinical Characteristics and Outcomes of Patients Hospitalized with COVID-19 at Case Hospital, Uganda

Table 1

Demographic and clinical characteristics at admission among participants with confirmed COVID-19 at case hospital.

Demographics	Frequency/median	Percentage/interquertile range
Age: (median, interquertile range) years	45	37–57
Age category
18–35	30	19.1
36–40	62	39.5
<18	4	2.6
≥50	61	38.9
Sex (n = 159)
Female	58	36.5
Male	101	63.5
Occupation
Formal	10	6.3
Informal	2	1.3
Unknown	148	92.5
Comorbidities
None	93	58.1
At least one comorbidity	67	41.9
Types of comorbidities
Hypertension	43	26.9
Diabetes	27	16.9
HIV	3	1.9
Others	13	8.1
Symptoms at admission
Dry cough	115	71.9
General body weakness	115	71.9
Dyspnoea	102	63.8
Fever	94	58.8
Chest pain	71	44.4
Chest discomfort	41	25.6
Sore throat	24	15
Headache	24	15
Loss of smell	18	11.3
Productive cough	18	11.3
Anorexia	7	4.4
Others	7	4.4
Chills	6	3.8
Diarrhea	5	3.1
Haemoptysis	3	1.9
Weight loss	1	0.6
Vital measurements	Median	Interquartile range
Systolic blood pressure (mmHg, n = 156)	131	117–144
Diastolic blood pressure (mmHg, n = 156)	80	73–90
Heart rate (beats per minute, n = 158)	90	80–104
Respiratory rate (breaths per minute, n = 95)	20	20–22
Temperature (°C, n = 151)	36	36–37
Random blood sugar (mmol/L, n = 40)	9	6–14
SPO2 (%, n = 158)	95	91–97
Length of hospitalization (days)	5	3–9

Other symptoms included vomiting, lower back pain, joint pains, convulsion, abdominal swelling, left-sided weakness, and altered mental state, in one patient each. Tachycardia (≥100 beats per minute) was present in 48 (30.4%) patients. Tachypnea (>20 breaths per minute) was present in 39 (41.1%) patients. Fever (≥38.0°C) was present in 11 (7.3%) patients. Hyperglycemia (≥11.1 mmol/L) was present in 18 (45%) patients. Hypoxia (<92%) was present in 41 (25.9%).